{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Plattsburgh",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89059",
      "recalling_firm": "SterRx, LLC",
      "address_1": "141 Idaho Ave",
      "address_2": "",
      "postal_code": "12903-3987",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "U.S.A. Nationwide",
      "recall_number": "D-0315-2022",
      "product_description": "dilTIAZem HCl in 5% Dextrose Injection, 125 mg per 125 mL, (32 mcg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-951-01.",
      "product_quantity": "8946 bags",
      "reason_for_recall": "Lack of Assurance of Sterility",
      "recall_initiation_date": "20211112",
      "center_classification_date": "20211229",
      "termination_date": "20231206",
      "report_date": "20220105",
      "code_info": "S21200/BVC 15-Nov-21  S21296/BYM 19-Dec-21  S21320/BZG 4-Jan-22  S21164/BTV 3-Dec-21  S21191/BUU 18-Dec-21  S21197/BUZ 31-Dec-21  S21220/BVV 13-Jan-22  S21271/BXO 27-Jan-22  S21272/BXP 28-Jan-22  S21299/BYP 18-Feb-22  S21300/BYQ 19-Feb-22",
      "more_code_info": ""
    }
  ]
}